Product Describtion:ML 145 is a selective and competitive human GPR35/CXCR8 antagonist with an IC50/EC50 of 20.1 nM. ML 145 has over 1000-fold more selective for GPR35 compared to GPR55 (IC50/EC50=21.7 μM)[1]. ML 145 has no significant activity for GPR35 at either rodent ortholog.
Specifications and Purity: ≥98%(HPLC)
Molecular Formula: C24H22N2O5S2
Molecular Weight: 482.57
PubChem CID: 2286812
Isomeric SMILES: C/C(=C/C1=CC=CC=C1)/C=C/2/C(=O)N(C(=S)S2)CCCC(=O)NC3=CC(=C(C=C3)C(=O)O)O
Related Documents: https://aladdin-for-icloud-store.oss-cn-hangzhou.aliyuncs.com/aladdinsci/pdp/sds/1/M287781-SCI_c5a71c9aa1504d0bce2d3b6c1c03786f.pdf
- UPC:
- 42182801
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- M287781-100mg
- CAS:
- 1164500-72-4
- Product Size:
- 100mg
- Precautionary Statement Codes:
- P264
akash.verma@cenmed.com
(732) 447-1115





